chevron_leftBack
As of 20 June 2026, Hindustan Bio Sciences Ltd. has a market cap of $1.0M USD, ranking #48566 globally and #5059 in India.
It ranks #4310 in the Healthcare sector, and #1357 in the Drug Manufacturers - General industry.
Key Stats
Market Cap
$1.0MUSD
94.41M INR
Enterprise Value
$1.28MUSD
120.41M INR
Revenue (TTM)
$120.27KUSD
11.35M INR
EBITDA (TTM)
$15.07KUSD
1.42M INR
Net Income (TTM)
$15.67KUSD
1.48M INR
EBITDA Margin
13%
Profit Margin
13%
PE Ratio
59.2
PS Ratio
8.3
PB Ratio
11.0
EV/EBITDA
84.6
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Jampana Venkata Rama Raju
open_in_new
Employees
2
Founded
1991
Website
hindustanbiosciences.in
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| 0% | -4.7% | 24% | 50% | 42% | 17% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
532041
(HINDBIO)
Hindustan Bio Sciences Ltd
ISIN: INE597C01021
Shares Out.:
Shares Outstanding:
10.251M1
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
9.21 INR |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Hindustan Bio Sciences Ltd.
Hindustan Bio Sciences Limited engages in the manufacturing and sale of pharmaceutical products in India. The company offers tablets, capsules, drops, externels, and syrups. It is also involved in marketing a nephrology product, recombinant human Erythropotien; and trading of drugs and medicines. In addition, the company exports its products. Hindustan Bio Sciences Limited was incorporated in 1991 and is based in Hyderabad, India.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NSE: SUNPHARMA
|
$45.22B
5M%
4.27T INR
|
39.1
|
|
NSE: DIVISLAB
|
$18.38B
2M%
1.73T INR
|
70.0
|
|
NSE: TORNTPHARM
|
$15.17B
2M%
1.43T INR
|
63.0
|
|
NSE: DRREDDY
|
$11.73B
1M%
1.11T INR
|
19.6
|
|
NSE: MANKIND
|
$9.87B
987K%
931.67B INR
|
52.2
|
|
NSE: ZYDUSLIFE
|
$9.71B
971K%
916.53B INR
|
18.6
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: LLY
|
$761.68B
76M%
|
38.1
|
|
NYSE: JNJ
|
$547.28B
55M%
|
26.4
|
|
NYSE: ABBV
|
$360.63B
36M%
|
97.4
|
|
SIX: RO
|
$318.3B
32M%
256.25B CHF
|
19.9
|
|
LSE: AZN
|
$284.64B
28M%
215.59B GBP
|
27.6
|
|
NYSE: MRK
|
$274.03B
27M%
|
15.1
|
chevron_leftBack